Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction.
Seña AC, Bachmann L, Johnston C, Wi T, Workowski K, Hook EW 3rd, Hocking JS, Drusano G, Unemo M. Seña AC, et al. Among authors: drusano g. Lancet Infect Dis. 2020 Aug;20(8):e181-e191. doi: 10.1016/S1473-3099(20)30171-7. Epub 2020 Jun 19. Lancet Infect Dis. 2020. PMID: 32569625 Free PMC article. Review.
Stepping Off the Resistance Treadmill.
Drusano GL. Drusano GL. J Infect Dis. 2017 Jul 15;216(2):150-152. doi: 10.1093/infdis/jix212. J Infect Dis. 2017. PMID: 28475769 No abstract available.
In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae.
Foerster S, Drusano G, Golparian D, Neely M, Piddock LJV, Alirol E, Unemo M. Foerster S, et al. Among authors: drusano g. J Antimicrob Chemother. 2019 Dec 1;74(12):3521-3529. doi: 10.1093/jac/dkz376. J Antimicrob Chemother. 2019. PMID: 31730160
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunities.
Theuretzbacher U, Barbee L, Connolly K, Drusano G, Fernandes P, Hook E, Jerse A, O'Donnell J, Unemo M, Van Bambeke F, VanScoy B, Warn P, Werth BJ, Franceschi F, Alirol E. Theuretzbacher U, et al. Among authors: drusano g. Clin Microbiol Infect. 2020 Dec;26(12):1630-1635. doi: 10.1016/j.cmi.2020.08.006. Epub 2020 Aug 13. Clin Microbiol Infect. 2020. PMID: 32798687 Free article. Review.
Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model.
Jacobsson S, Golparian D, Oxelbark J, Alirol E, Franceschi F, Gustafsson TN, Brown D, Louie A, Drusano G, Unemo M. Jacobsson S, et al. Among authors: drusano g. Front Pharmacol. 2021 May 21;12:682135. doi: 10.3389/fphar.2021.682135. eCollection 2021. Front Pharmacol. 2021. PMID: 34093206 Free PMC article.
Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model.
Jacobsson S, Golparian D, Oxelbark J, Franceschi F, Brown D, Louie A, Drusano G, Unemo M. Jacobsson S, et al. Among authors: drusano g. Front Pharmacol. 2022 Apr 14;13:874176. doi: 10.3389/fphar.2022.874176. eCollection 2022. Front Pharmacol. 2022. PMID: 35496288 Free PMC article.
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
Unemo M, Golparian D, Oxelbark J, Kong FYS, Brown D, Louie A, Drusano G, Jacobsson S. Unemo M, et al. Among authors: drusano g. J Antimicrob Chemother. 2024 May 2;79(5):1006-1013. doi: 10.1093/jac/dkae063. J Antimicrob Chemother. 2024. PMID: 38497988
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Among authors: drusano g. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
392 results